Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Status:
Active, not recruiting
Trial end date:
2024-08-21
Target enrollment:
Participant gender:
Summary
This research will help us to learn if the medicine called metformin reduces the risk of
death, heart attacks, and/or strokes in patients who have pre-diabetes and heart or blood
vessel problems.